BVI unveils dual cataract, vitreoretinal surgical platform
September 4, 2025
Ophthalmic device company BVI Medical unveiled its new Virtuoso phaco-vitrectomy surgical platform.
Ophthalmic device company BVI Medical unveiled its new Virtuoso phaco-vitrectomy surgical platform.
Daye has just launched a comprehensive at-home hormone testing service across the UK, and Med-Tech Insights spoke to Valentina Milanova, founder & CEO of Daye to find out more.
Tasso, a specialist in patient-centric blood collection, and SheMed, a UK-based women’s healthcare company, have teamed up to deliver safer, more personalised weight loss treatments through convenient at-home diagnostics.
The technology is compatible with all PTFE grafts and was studied extensively in the company’s pivotal clinical trial
GE HealthCare (Nasdaq: GEHC)+
today announced the launch of Vivid Pioneer, its newest, most advanced cardiovascular ultrasound system.
A first-of-its-kind Blood Pressure Treatment Efficacy Calculator built on data from nearly 500 randomized clinical trials in over 100,000 people allows doctors to see how much different medications are likely to lower blood pressure.
PocDoc, a leading UK digital health diagnostics company, has launched what it says is the world’s first smartphone-based test for type 2 diabetes risk including the gold-standard blood biomarker, HbA1c, a landmark step in diabetes prevention according to the company.
Northwestern unveils NIH Baby Toolbox, the newest national standard to assess infants’ cognitive, emotional growth
OSTRAVA, Czech Republic, Aug. 19, 2025 /PRNewswire/ — Stimvia, a medtech company based in the Czech Republic, has successfully completed a clinical study on peroneal electrical transcutaneous neuromodulation (peroneal eTNM®) through its URIS® device to treat Parkinson’s disease symptoms.
West Nile virus (WNV) has been the dominant cause of mosquito-borne illness in the United States since its introduction into North America in 1999. There are no vaccines nor medications to prevent or treat illness in people, so surveillance, prevention, and control remain the best options to protect the public.